Biocompatible member and method for manufacturing same

US2024425809A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2024425809-A1
Application numberUS-202418828533-A
CountryUS
Kind codeA1
Filing dateSep 9, 2024
Priority dateMar 16, 2022
Publication dateDec 26, 2024
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A biocompatible member according to an embodiment is a biocompatible member including multiple fibers including a biocompatible material. Mutually adjacent fibers among the fibers are covalently bonded at multiple locations in an extension direction of the fibers.

First claim

Opening claim text (preview).

What is claimed is: 1 . A biocompatible member, comprising: a plurality of fibers including a biocompatible material, mutually-adjacent fibers among the fibers being covalently bonded at a plurality of locations in an extension direction of the fibers. 2 . The biocompatible member according to claim 1 , wherein the fibers extend in a first direction in a first region, the fibers extend in a second direction crossing the first direction in a second region, the first region and the second region are stacked, and at a boundary between the first region and the second region, a plurality of the fibers adjacent to one of the fibers in a stacking direction is covalently bonded to the one of the fibers. 3 . The biocompatible member according to claim 2 , wherein a compressive elastic modulus of the biocompatible member in the stacking direction is not less than 5 kPa. 4 . The biocompatible member according to claim 2 , wherein a storage modulus is greater than a loss modulus in a region from room temperature to 90° C. when a viscoelasticity-temperature curve of the biocompatible member is measured by a dynamic viscoelastic technique. 5 . The biocompatible member according to claim 2 , wherein the first region and the second region are alternately stacked. 6 . The biocompatible member according to claim 1 , wherein the extension direction of the fibers are uniform in one region. 7 . The biocompatible member according to claim 1 , wherein atoms in the biocompatible material are directly covalently bonded to each other. 8 . The biocompatible member according to claim 1 , wherein the covalent bonding is performed by crosslinking, the biocompatible member does not include a chemically crosslinked component, and adjacent fibers among the fibers in the biocompatible member are thermally crosslinked. 9 . The biocompatible member according to claim 1 , wherein a shape of the biocompatible member is maintained even when immersed in a culture medium for 6 days at 37° C. 10 . The biocompatible member according to claim 1 , further comprising: a liquid having water as a major component, a content ratio of the liquid being not less than 40 mass % and not more than 90 mass %. 11 . The biocompatible member according to claim 10 , wherein the liquid is at least one of purified water, a physiologic saline solution, serum, a liquid culture medium, protein, RNA, DNA, an aqueous solution including a substrate, a suspension of a cell, a body fluid, and blood. 12 . The biocompatible member according to claim 1 , wherein voids having diameters of not less than 10 μm are provided in a surface of the biocompatible member at a density of not less than 1/mm 2 . 13 . The biocompatible member according to claim 1 , wherein the biocompatible material is collagen. 14 . The biocompatible member according to claim 13 , wherein the collagen is higher-order collagen having a three-dimensional structure. 15 . The biocompatible member according to claim 14 , wherein the biocompatible member is transparent or semi-transparent. 16 . The biocompatible member according to claim 1 , wherein the biocompatible member is sheet-like, and a thickness of the biocompatible member is not less than 0.03 mm and not more than 50 mm. 17 . A method for manufacturing a biocompatible member, comprising: forming a deposited body by depositing fibers including a biocompatible material; causing a liquid to penetrate the deposited body, the liquid being volatile; volatilizing the liquid that penetrated the deposited body; and performing thermal crosslinking treatment of the deposited body after the liquid is volatilized in an environment decompressed from atmospheric pressure, the forming of the deposited body including making extension directions of the deposited fibers uniform by pulling the fibers in one direction, the penetration of the volatile liquid including reducing a distance between mutually-adjacent fibers among the fibers by a capillary force acting between the mutually-adjacent fibers among the fibers, the thermal crosslinking treatment including covalently bonding the fibers having the reduced distance to each other at a plurality of locations. 18 . The method for manufacturing the biocompatible member according to claim 17 , wherein the penetration of the volatile liquid includes forming a space in the deposited body not filled with the volatile liquid. 19 . The method for manufacturing the biocompatible member according to claim 17 , further comprising: performing hydrostatic pressure treatment of the deposited body after the thermal crosslinking treatment. 20 . The method for manufacturing the biocompatible member according to claim 17 , wherein the thermal crosslinking treatment includes exposing the deposited body after the liquid is volatilized to an atmosphere having a pressure of not more than 10 Pa and a temperature of not less than 100° C. and not more than 200° C.

Assignees

Inventors

Classifications

  • Cross-linking · CPC title

  • Collagen; Gelatin · CPC title

  • C12N5/0068Primary

    General culture methods using substrates (for specific animal cell type C12N5/06) · CPC title

  • Materials for use in artificial skin · CPC title

  • Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2024425809A1 cover?
A biocompatible member according to an embodiment is a biocompatible member including multiple fibers including a biocompatible material. Mutually adjacent fibers among the fibers are covalently bonded at multiple locations in an extension direction of the fibers.
Who is the assignee on this patent?
National Univ Corporation Tokyo Medical And Dental Univeristy, Toshiba Kk
What technology area does this patent fall under?
Primary CPC classification C12N5/0068. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Dec 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).